PMV Pharmaceuticals (PMVP) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on PMV Pharmaceuticals (PMVP) is Neutral.

The composite score behind that read is -0.06, weighing +0.25 of bullish evidence against -0.32 bearish.

PMV Pharmaceuticals last closed at $1.52, +2.01% on the session.

Against the IVW growth benchmark the position is +1.21% over the forecast window.

The read is built from 15 underlying insights — 2 bullish and 13 bearish.

Agreement across those insights is 87%.

20 graded predictions for PMVP so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks PMV Pharmaceuticals in the 13th percentile on return on equity, where 100 is best.

PMV Pharmaceuticals is classified under Health Care / Biotechnology, with a market capitalisation of $112.52M.

StockMap tracks PMV Pharmaceuticals as the 279th largest of the 381 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 301 Neutral, 63 Moderate Underperform and 17 Moderate Outperform.

On that composite PMV Pharmaceuticals ranks 171st of 381 in the group, against a group median of -0.08.